1. The Garvan Institute of Medical Research, Sydney, NSW, Australia;
2. St. Vincent’s School of Medicine, University of New South Wales, Sydney, NSW, Australia;
3. Dana-Farber Cancer Institute, Boston, MA;
4. Maine Medical Center Research Institute, Scarborough, ME;
5. UniversitätsKlinikum Heidelberg, Medizinische Klinik V, Labors für Myelomforschung, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany;
6. Centre for Children’s Bone and Musculoskeletal Health, The Children’s Hospital at Westmead, Sydney, NSW, Australia;
7. Novartis Institutes for Biomedical Research, Basel, Switzerland;
8. Faculty of Medicine, Department of Hematology and Immunology, Frei University, Brussels, Belgium;
9. Department of Medicine, Molecular Endocrinology Laboratory, Imperial College, London, United Kingdom; and
10. University of Texas Health Science Center, San Antonio, TX